Search

Lysate of engineered Escherichia coli supports high-level conversion of glucose to 2,3-butanediol

메타 데이터

바이오화학분류
    • 바이오정밀화학
      1. 용매
      2. 화학제품
논문

Lysate of engineered Escherichia coli supports high-level conversion of glucose to 2,3-butanediol

학술지

Metabolic engineering

저자명

Kay, Jennifer E.; Jewett, Michael C.

초록

<P><B>Abstract</B></P> <P>Cell-free metabolic engineering (CFME) is emerging as a powerful approach for the production of target molecules and pathway debugging. Unfortunately, high cofactor costs, limited cofactor and energy regeneration, and low volumetric productivities hamper the widespread use and practical implementation of CFME technology. To address these challenges, we have developed a cell-free system that harnesses ensembles of catalytic proteins prepared from crude lysates, or extracts, of cells to fuel highly active heterologous metabolic conversions. As a model pathway, we selected conversion of glucose to 2,3-butanediol (2,3-BD), a medium level commodity chemical with many industrial applications. Specifically, we engineered a single strain of <I>Escherichia coli</I> to express three pathway enzymes necessary to make <I>meso</I>-2,3-BD (m2,3-BD). We then demonstrated that lysates from this strain, with addition of glucose and catalytic amounts of cofactors NAD+ and ATP, can produce m2,3-BD. Endogenous glycolytic enzymes convert glucose to pyruvate, the starting intermediate for m2,3-BD synthesis. Strikingly, with no strain optimization, we observed a maximal synthesis rate of m2,3-BD of 11.3&plusmn;0.1g/L/h with a theoretical yield of 71% (0.36gm2,3-BD/g glucose) in batch reactions. Titers reached 82&plusmn;8g/Lm2,3-BD in a 30h fed-batch reaction. Our results highlight the ability for high-level co-factor regeneration in cell-free lysates. Further, they suggest exciting opportunities to use lysate-based systems to rapidly prototype metabolic pathways and carry out molecular transformations when bioconversion yields (g product/L), productivities (g product/L/h), or cellular toxicity limit commercial feasibility of whole-cell fermentation.</P> <P><B>Highlights</B></P> <P> <UL> <LI> Highly active metabolic conversions were activated in a cell-free environment. </LI> <LI> Native glycolytic enzymes support a heterologous pathway in crude extracts. </LI> <LI> NADH is regenerated and recycled using native enzymes. </LI> <LI> Achieved 82gL<SUP>&minus;1</SUP> titer with 11.3gL<SUP>&minus;1</SUP> h<SUP>&minus;1</SUP> peak volumetric productivity in 30h. </LI> </UL> </P> <P><B>Graphical abstract</B></P> <P>[DISPLAY OMISSION]</P>

발행연도

2015

발행기관

Elsevier

라이선스

publisher-specific-oa

ISSN

1096-7176

ISSN

1096-7184

32

페이지

pp.133-142

주제어

Cell-free metabolic engineering; Cell-free synthetic biology; 2,3-butanediol; Escherichia coli; In vitro; Cofactor regeneration

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2015-11-01

Export

About

Search

Trend